The kidney toxicity mechanism, specifically the breakdown of D-amino acids by renal enzymes, would likely make extended continuous use problematic
CJC-1295 Best for: Sustained growth-hormone-axis stimulation for lean mass and recovery support CJC-1295 is a synthetic growth-hormone-releasing hormone (GHRH) analog, a modified 29-amino-acid peptide originally developed by ConjuChem Biotechnologies
We found a wealth of anecdotal and professional opinion on its use
Some practitioners in the peptide community do recommend stacking AOD 9604 with GLP-1 agonists, particularly for patients who want to maximize fat loss while minimizing muscle loss
But he was also cautious about whether TB-500 at that level was correct, given the different dosing needs of each compound
There are thousands of studies, which have proven the method to be safe and effective in its application